Patents by Inventor Sheila Keating

Sheila Keating has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Recombinant polyclonal proteins and methods of use thereof
    Patent number: 12590386
    Abstract: Provided herein are compositions comprising recombinant polyclonal proteins (RPPs) derived from mammalian plasma cells and plasmablasts. Also provided are methods of using the RPPs.
    Type: Grant
    Filed: April 30, 2020
    Date of Patent: March 31, 2026
    Assignee: GigaGen, Inc.
    Inventors: David Scott Johnson, Adam Shultz Adler, Rena Aviva Mizrahi, Yoong Wearn Lim, Michael Asensio, Sheila Keating, Renee Leong, Jackson Leong
  • RECOMBINANT POLYCLONAL PROTEINS TARGETING COVID-19 AND METHODS OF USE THEREOF
    Publication number: 20260015770
    Abstract: Provided herein are compositions comprising recombinant polyclonal proteins (RPPs) derived from mammalian plasma cells and plasmablasts. Also provided are methods of using the RPPs.
    Type: Application
    Filed: July 31, 2025
    Publication date: January 15, 2026
    Inventors: David Scott Johnson, Sheila Keating, Adam Shultz Adler, Michael Asensio, Kacy Stadtmiller, Emily Benzie, Ariel Niedecken, Angelica V. Medina-Cucurella, Rena Aviva Mizrahi, Yoong Wearn Lim
  • Recombinant polyclonal proteins targeting COVID-19 and methods of use thereof
    Patent number: 12404607
    Abstract: Provided herein are compositions comprising recombinant polyclonal proteins (RPPs) derived from mammalian plasma cells and plasmablasts. Also provided are methods of using the RPPs.
    Type: Grant
    Filed: April 4, 2023
    Date of Patent: September 2, 2025
    Assignee: GigaGen, Inc.
    Inventors: David Scott Johnson, Sheila Keating, Adam Shultz Adler, Michael Asensio, Kacy Stadtmiller, Emily Benzie, Ariel Niedecken, Angelica V. Medina-Cucurella, Rena Aviva Mizrahi, Yoong Wearn Lim
  • RECOMBINANT POLYCLONAL PROTEINS TARGETING COVID-19 AND METHODS OF USE THEREOF
    Publication number: 20230287112
    Abstract: Provided herein are compositions comprising recombinant polyclonal proteins (RPPs) derived from mammalian plasma cells and plasmablasts. Also provided are methods of using the RPPs.
    Type: Application
    Filed: April 4, 2023
    Publication date: September 14, 2023
    Inventors: David Scott Johnson, Sheila Keating, Adam Shultz Adler, Michael Asensio, Kacy Stadtmiller, Emily Benzie, Ariel Niedecken, Angelica V. Medina-Cucurella, Rena Aviva Mizrahi, Yoong Wearn Lim
  • RECOMBINANT POLYCLONAL PROTEINS TARGETING ZIKA AND METHODS OF USE THEREOF
    Publication number: 20230265171
    Abstract: Provided herein are compositions comprising recombinant polyclonal protein (RPP) derived from mammalian plasma cells and plasmablasts. Specifically, RPPs specific to Zika virus are provided. Also provided are the methods of using the RPP for treatment of viral infection and the methods of making the RPPs.
    Type: Application
    Filed: April 27, 2023
    Publication date: August 24, 2023
    Inventors: David Scott JOHNSON, Sheila KEATING, Adam Shultz ADLER, Michael ASENSIO, Kacy STADTMILLER, Emily BENZIE, Ariel NIEDECKEN, Angelica V. Medina-Cucurella, Rena Aviva MIZRAHI, Yoong Wearn LIM
  • Recombinant polyclonal proteins targeting Zika and methods of use thereof
    Patent number: 11718660
    Abstract: Provided herein are compositions comprising recombinant polyclonal protein (RPP) derived from mammalian plasma cells and plasmablasts. Specifically, RPPs specific to Zika virus are provided. Also provided are the methods of using the RPP for treatment of viral infection and the methods of making the RPPs.
    Type: Grant
    Filed: September 8, 2021
    Date of Patent: August 8, 2023
    Assignee: GigaGen, Inc.
    Inventors: David Scott Johnson, Sheila Keating, Adam Shultz Adler, Michael Asensio, Kacy Stadtmiller, Emily Benzie, Ariel Niedecken, Angelica V. Medina-Cucurella, Rena Aviva Mizrahi, Yoong Wearn Lim
  • Recombinant polyclonal proteins targeting COVID-19 and methods of use thereof
    Patent number: 11685779
    Abstract: Provided herein are compositions comprising recombinant polyclonal proteins (RPPs) derived from mammalian plasma cells and plasmablasts. Also provided are methods of using the RPPs.
    Type: Grant
    Filed: July 27, 2021
    Date of Patent: June 27, 2023
    Assignee: GigaGen, Inc.
    Inventors: David Scott Johnson, Sheila Keating, Adam Shultz Adler, Michael Asensio, Kacy Stadtmiller, Emily Benzie, Ariel Niedecken, Angelica V. Medina-Cucurella, Rena Aviva Mizrahi, Yoong Wearn Lim
  • Recombinant Polyclonal Proteins and Methods of Use Thereof
    Publication number: 20220243197
    Abstract: Provided herein are compositions comprising recombinant polyclonal proteins (RPPs) derived from mammalian plasma cells and plasmablasts. Also provided are methods of using the RPPs.
    Type: Application
    Filed: April 30, 2020
    Publication date: August 4, 2022
    Inventors: David Scott Johnson, Adam Shultz Adler, Rena Aviva Mizrahi, Yoong Wearn Lim, Michael Asensio, Sheila Keating, Renee Leong, Jackson Leong
  • RECOMBINANT POLYCLONAL PROTEINS TARGETING ZIKA AND METHODS OF USE THEREOF
    Publication number: 20220064268
    Abstract: Provided herein are compositions comprising recombinant polyclonal protein (RPP) derived from mammalian plasma cells and plasmablasts. Specifically, RPPs specific to Zika virus are provided. Also provided are the methods of using the RPP for treatment of viral infection and the methods of making the RPPs.
    Type: Application
    Filed: September 8, 2021
    Publication date: March 3, 2022
    Inventors: David Scott Johnson, Sheila Keating, Adam Shultz Adler, Michael Asensio, Kacy Stadtmiller, Emily Benzie, Ariel Niedecken, Angelica V. Medina-Cucurella, Rena Aviva Mizrahi, Yoong Wearn Lim
  • RECOMBINANT POLYCLONAL PROTEINS TARGETING COVID-19 AND METHODS OF USE THEREOF
    Publication number: 20220041715
    Abstract: Provided herein are compositions comprising recombinant polyclonal proteins (RPPs) derived from mammalian plasma cells and plasmablasts. Also provided are methods of using the RPPs.
    Type: Application
    Filed: July 27, 2021
    Publication date: February 10, 2022
    Inventors: David Scott Johnson, Sheila Keating, Adam Shultz Adler, Michael Asensio, Kacy Stadtmiller, Emily Benzie, Ariel Niedecken, Angelica V. Medina-Cucurella, Rena Aviva Mizrahi, Yoong Wearn Lim
  • Lightweight decorative barrette
    Publication number: 20070079846
    Abstract: A barrette having a decorative attachment affixed along the arching outer surface of the top support member of a barrette base, and the folded ends of the attachment are tucked and attached beneath the ends of the top support member. The decorative attachment is affixed to the top support member of the base, using tape, hot-glue, thread, rivets, or any suitable fastener. The decorative attachment comprises layers of cotton webbing, plastic mesh, and grosgrain ribbon. Decorative material is applied atop the decorative attachment for added aesthetic appeal. Fray blocking agent is applied to the edges of the decorative material. Zigzag stitches may be sewn into the decorative material.
    Type: Application
    Filed: October 5, 2006
    Publication date: April 12, 2007
    Inventor: Sheila Keating